Skip to main navigation Skip to search Skip to main content

Two-Lever Drug-Drug Discrimination with the 5-HT1 Receptor Agonists Flesinoxan and Eltoprazine

  • J. Gommans
  • , T.H. Hijzen
  • , R.A.A. Maes
  • , B. Olivier

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)221-228
Number of pages8
JournalInternational Journal of Neuropsychopharmacology
Volume3
Publication statusPublished - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Medical technology
  • Farmacie(FARM)
  • Bescherming en bevordering van de menselijke gezondheid
  • Biomedische technologie en medicijnen
  • Public Health
  • Analytical chemistry
  • Drugmisbruik en verslaving

Cite this